Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France.
about
Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis.Cost-effectiveness of colorectal cancer screening - an overview.Cost-effectiveness of colorectal cancer screening protocols in urban Chinese populations.Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines updateCost-effectiveness of colorectal cancer screeningGuaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening ProgrammeComparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk populationCost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful informationReview of economic evidence in the prevention and early detection of colorectal cancer.Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screening.The influence of waiting times on cost-effectiveness: a case study of colorectal cancer mass screening.
P2860
Q33774326-FEEFDA6F-B35F-4322-88C3-EDA682EC0404Q34125840-C36B4F57-FF30-4E2E-A45C-EC4359882A15Q34294226-E700A7F6-B306-4A20-AEFA-FC8FCA4BAC1BQ34441837-B1B32122-DFF7-4770-8061-9E2EB727819FQ35095108-6CFFA199-6BD5-4E6E-A916-8FA10642BA32Q35678074-5ED983E2-8379-4B20-B6B3-44D6F26055D5Q35761319-3BAB0BF9-1C5C-4CD7-A17C-6D85FF17C778Q35809264-700BC1A5-91B9-4868-ADB5-3694D9C858ACQ36711336-55FA7C7B-F02E-4033-B6B2-0A3134347419Q37356637-FE33D842-10CA-4A9B-AC07-7DC89DA0ED5CQ37395173-27B17DE9-6687-4BCA-BA5A-734D8A8B29CDQ39911365-CF143B09-6041-426E-9822-77CCFF0372B7Q51788992-8C435886-BA8C-4D60-A15D-B0F5F94FEA60
P2860
Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Cost-effectiveness analysis of ...... r colorectal cancer in France.
@ast
Cost-effectiveness analysis of ...... r colorectal cancer in France.
@en
Cost-effectiveness analysis of ...... r colorectal cancer in France.
@nl
type
label
Cost-effectiveness analysis of ...... r colorectal cancer in France.
@ast
Cost-effectiveness analysis of ...... r colorectal cancer in France.
@en
Cost-effectiveness analysis of ...... r colorectal cancer in France.
@nl
prefLabel
Cost-effectiveness analysis of ...... r colorectal cancer in France.
@ast
Cost-effectiveness analysis of ...... r colorectal cancer in France.
@en
Cost-effectiveness analysis of ...... r colorectal cancer in France.
@nl
P2093
P356
P1433
P1476
Cost-effectiveness analysis of ...... r colorectal cancer in France.
@en
P2093
Célia Berchi
Guy Launoy
Jean-Marie Réaud
Véronique Bouvier
P304
P356
10.1002/HEC.819
P407
P577
2004-03-01T00:00:00Z